Dendrimers News

RSS

The Realization of a More Stable and Powerful Li-Metal Battery

The Next-Generation Battery Research Center of the Korea Electrotechnology Research Institute conducted a study on Li-metal batteries, which was later published as a cover paper in a prestigious international journal.

30 Aug 2022

Newly Designed Nanodiamonds Could Enhance Drug Cellular Uptake

Scientists have recently developed newly designed nanodiamonds that exhibited a high potential as a candidate for drug delivery in cancer cells.

28 Jun 2022

Economical Approach to 3D High-Performance Lithium Metal Anodes

A scalable and cost-effective technique for generating three-dimensional, structural, highly efficient lithium (Li) metal anodes is suggested, opening up new avenues for studies into Li metal and potentially other metal anodes.

18 May 2022

Researchers Integrate Several Dendrimer Structures to Create a Supramolecular Capsule

Nanoparticles, with sizes ranging from 3–500 nm, and sub-nanoclusters, with approximately 1 nm diameter, are used in several areas, such as robotics, materials science, medicine, and engineering. They have unique properties, owing to their tiny size and huge surface-area-to-volume ratios, which make them beneficial in a wide range of applications, from pollution control to chemical synthesis.

7 Mar 2022

Researchers Synthesize Metal Nanoparticle Catalysts for Oxidizing Hydrocarbons

Apart from being the chief constituents of natural gas and petroleum, hydrocarbons and their blends have a crucial role as resources that support present-day infrastructure as basic materials for the petrochemical sector.

1 Aug 2017

Research Report on Global Dendrimers Market

Research and Markets has announced the addition of the "The Global Market for Dendrimers, 2010-2025" report to their offering.

From Research and Markets 28 Apr 2015

ProLynx Obtains US Patent 8,703,907 Covering Controlled Drug Release from Dendrimer Conjugates

ProLynx LLC, a biotechnology company focused on development of disruptive drug delivery systems for half-life extension of injectable drugs today announced that the United States Patent and Trademark Office has issued US Patent 8,703,907 covering controlled release of drugs from dendrimer conjugates over prolonged periods.

23 Apr 2014